• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别与共病疼痛和阿片类药物使用障碍:范围综述。

Sex differences in comorbid pain and opioid use disorder: A scoping review.

机构信息

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.

VISN 1 Mental Illness Research, Education, and Clinical Center (MIRECC), VA Bedford Healthcare System, Bedford, MA, USA.

出版信息

Br J Clin Pharmacol. 2024 Dec;90(12):3067-3083. doi: 10.1111/bcp.16218. Epub 2024 Aug 21.

DOI:10.1111/bcp.16218
PMID:39168150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11604518/
Abstract

Opioid use disorder (OUD) and chronic pain are commonly co-occurring disorders which can exacerbate each other. Sex/gender differences have been shown in aspects of the clinical course and biological underpinnings of both OUD and chronic pain. The purpose of this scoping review is to summarize literature which has addressed sex/gender differences in relation to the confluence of OUD and chronic pain. This review focused on peer-reviewed journal articles with human subjects and addressing (a) opioid misuse, chronic opioid use or opioid use disorder (OUD), (b) chronic or persistent pain and (c) sex/gender differences in relation to OUD and/or chronic pain. Of the 146 papers identified by the search strategy, 30 met the criteria for inclusion. Charting focused on a priori themes of chronic pain, opioid misuse/OUD and sex/gender in sample, predictor and outcome variables, and key study findings. The majority of research identified was cross-sectional in nature, and sex/gender differences and treatment effects were largely included as post-hoc analyses. Together, the results of this early work align with higher prevalence for OUD in men/males and chronic pain in women/females, while adding critical information with respect to potential sex/gender differences in the development and treatment of their co-occurrence across a range of biological and psychosocial factors. Findings underline the importance of considering sex and gender in the intersection of the development and treatment of OUD and chronic pain.

摘要

阿片类使用障碍(OUD)和慢性疼痛是常见的共病,会相互加重。OUD 和慢性疼痛的临床病程和生物学基础都存在性别差异。本综述的目的是总结文献中关于 OUD 和慢性疼痛共病相关的性别差异。本综述重点关注了有人类受试者参与的同行评审期刊文章,这些文章涉及(a)阿片类药物滥用、慢性阿片类药物使用或阿片类药物使用障碍(OUD),(b)慢性或持续性疼痛,以及(c)与 OUD 和/或慢性疼痛相关的性别差异。通过搜索策略确定了 146 篇论文,其中 30 篇符合纳入标准。图表重点关注慢性疼痛、阿片类药物滥用/OUD 和样本、预测和结果变量中的性别差异的先验主题,以及关键研究发现。已确定的大多数研究具有横断面性质,性别差异和治疗效果主要作为事后分析纳入。总的来说,这项早期工作的结果与 OUD 在男性中的更高患病率和慢性疼痛在女性中的更高患病率一致,同时在一系列生物和心理社会因素的共病发展和治疗方面,提供了关于潜在性别差异的重要信息。这些发现强调了在 OUD 和慢性疼痛的发展和治疗中考虑性别的重要性。

相似文献

1
Sex differences in comorbid pain and opioid use disorder: A scoping review.性别与共病疼痛和阿片类药物使用障碍:范围综述。
Br J Clin Pharmacol. 2024 Dec;90(12):3067-3083. doi: 10.1111/bcp.16218. Epub 2024 Aug 21.
2
Analgesic Opioid Misuse and Opioid Use Disorder among Patients with Chronic Non-Cancer Pain and Prescribed Opioids in a Pain Centre in France.法国某疼痛中心慢性非癌痛患者阿片类药物滥用和阿片类药物使用障碍与处方阿片类药物
Int J Environ Res Public Health. 2021 Feb 21;18(4):2097. doi: 10.3390/ijerph18042097.
3
Trends of Opioid Use Disorder Among Hospitalized Patients With Chronic Pain.慢性疼痛住院患者中阿片类药物使用障碍的趋势。
Pain Pract. 2019 Jul;19(6):656-663. doi: 10.1111/papr.12789. Epub 2019 Jun 17.
4
Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain.欧洲裔慢性非癌痛患者中,吸烟与阿片类药物使用障碍的独立关联。
Drug Alcohol Depend. 2020 Apr 1;209:107901. doi: 10.1016/j.drugalcdep.2020.107901. Epub 2020 Feb 14.
5
Alcohol and Opioid Use, Co-Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review.酒精和阿片类物质使用、共同使用与阿片类药物流行背景下的慢性疼痛:批判性综述。
Alcohol Clin Exp Res. 2018 Mar;42(3):478-488. doi: 10.1111/acer.13594. Epub 2018 Feb 6.
6
Study Protocol for the Healing Opioid Misuse and Pain Through Engagement Trial: Integrated Treatment for Individuals With Co-occurring Chronic Pain and Opioid Use Disorder.通过参与试验治愈阿片类药物滥用和疼痛的研究方案:针对慢性疼痛和阿片类药物使用障碍并发个体的综合治疗
Subst Use Addctn J. 2025 Jan;46(1):192-196. doi: 10.1177/29767342241228126. Epub 2024 Jan 31.
7
The silence of opioids-dependent chronic pain patients: A text mining analysis from sex and gender perspective.阿片类药物依赖慢性疼痛患者的沉默:基于性别视角的文本挖掘分析
PLoS One. 2025 Mar 18;20(3):e0319574. doi: 10.1371/journal.pone.0319574. eCollection 2025.
8
Epigenetic and sex differences in opioid use disorder in chronic pain: A real-world study linked with OPRM1 DNA methylation.慢性疼痛患者阿片类药物使用障碍的表观遗传和性别差异:与 OPRM1 DNA 甲基化相关的真实世界研究。
Addict Biol. 2024 Jul;29(7):e13422. doi: 10.1111/adb.13422.
9
Impact of reported NSAID "allergies" on opioid use disorder in back pain.报告的 NSAID“过敏”对背痛阿片类药物使用障碍的影响。
J Allergy Clin Immunol. 2021 Apr;147(4):1413-1419. doi: 10.1016/j.jaci.2020.08.025. Epub 2020 Sep 9.
10
Posttraumatic stress disorder and chronic pain are associated with opioid use disorder: Results from a 2012-2013 American nationally representative survey.创伤后应激障碍和慢性疼痛与阿片类药物使用障碍有关:来自 2012-2013 年美国全国代表性调查的结果。
Drug Alcohol Depend. 2018 Jul 1;188:119-125. doi: 10.1016/j.drugalcdep.2018.04.005. Epub 2018 May 7.

引用本文的文献

1
Income-Based Disparities in Opioid Prescription Dispensing Among Public Drug Plan Beneficiaries in Canada from 2010 to 2018: A Population-Based and Sex-Stratified Retrospective Study.2010年至2018年加拿大公共药品计划受益人中基于收入的阿片类药物处方配药差异:一项基于人群和性别分层的回顾性研究。
Drugs Real World Outcomes. 2025 May 30. doi: 10.1007/s40801-025-00498-7.
2
Editorial for the themed issue: Addressing the dual challenges of opioid use disorder and chronic pain in the context of the opioid crisis.主题特刊社论:在阿片类药物危机背景下应对阿片类药物使用障碍和慢性疼痛的双重挑战。
Br J Clin Pharmacol. 2024 Dec;90(12):2960-2961. doi: 10.1111/bcp.16273. Epub 2024 Sep 27.

本文引用的文献

1
Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain.接受阿片类药物使用障碍药物治疗的个体在其一生中所经历的创伤:按性别、创伤后应激障碍状态和慢性疼痛的差异
Subst Abuse Treat Prev Policy. 2024 May 3;19(1):25. doi: 10.1186/s13011-024-00608-8.
2
Sex differences in pain catastrophizing and its relation to the transition from acute pain to chronic pain.疼痛灾难化的性别差异及其与急性疼痛向慢性疼痛转变的关系。
BMC Anesthesiol. 2024 Apr 2;24(1):127. doi: 10.1186/s12871-024-02496-8.
3
Estradiol and Mu opioid-mediated reward: The role of estrogen receptors in opioid use.
雌二醇与μ阿片类物质介导的奖赏:雌激素受体在阿片类物质使用中的作用
Addict Neurosci. 2023 Dec 15;9. doi: 10.1016/j.addicn.2023.100139. Epub 2023 Nov 25.
4
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors.《药理学简明指南 2023/24》:催化型受体。
Br J Pharmacol. 2023 Oct;180 Suppl 2:S241-S288. doi: 10.1111/bph.16180.
5
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes.《药理学简明指南 2023/24:酶》
Br J Pharmacol. 2023 Oct;180 Suppl 2:S289-S373. doi: 10.1111/bph.16181.
6
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.《药理学简明指南 2023/24:G 蛋白偶联受体》
Br J Pharmacol. 2023 Oct;180 Suppl 2:S23-S144. doi: 10.1111/bph.16177.
7
Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences.CYP2D6基因分型对阿片类药物使用障碍减药的影响:一项针对慢性疼痛且存在性别差异的前瞻性观察研究。
Front Pharmacol. 2023 May 31;14:1200430. doi: 10.3389/fphar.2023.1200430. eCollection 2023.
8
Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis.阿片类药物和兴奋剂药物的过量死亡率男性显著高于女性:州级分析。
Neuropsychopharmacology. 2023 Oct;48(11):1639-1647. doi: 10.1038/s41386-023-01601-8. Epub 2023 Jun 15.
9
Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences.慢性疼痛和阿片类药物使用障碍患者的长期减药:药物遗传学和性别差异。
Acta Pharm. 2023 Jun 12;73(2):227-241. doi: 10.2478/acph-2023-0018. Print 2023 Jun 1.
10
Sex Differences in Opioid Response Linked to and genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain.慢性疼痛患者中阿片类药物反应的性别差异与 和 基因的DNA甲基化/基因型变化有关。
J Clin Med. 2023 May 13;12(10):3449. doi: 10.3390/jcm12103449.